Navigation Links
A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
Date:11/20/2007

ied. Previously, we needed up to twelve work steps from patient positioning on the MRI table to data acquisition, but today we only need six," said Jorg Barkhausen, M.D., assistant medical director and acting head, University Hospital Essen, Germany. "This saves time and also reduces costs while increasing diagnostic safety. At the same time, syngo TimCT improves the image quality as the body region just being scanned is in the center of the magnet."

Advances in MRI Breast Spectroscopy

A recent study published in Radiology found that proton MRI spectroscopy may eliminate 68 percent of biopsies for benign non-mass breast lesions found on standard MRI exams without missing any cancers.(1) Siemens' solution for quantitative MRI breast spectroscopy, syngo GRACE, allows physicians to obtain essential metabolic information about the biochemical composition of breast lesions. This additional information helps physicians better distinguish between malignant and benign lesions to potentially reduce the risk of unnecessary breast biopsies. Using choline as a biomarker, syngo GRACE provides improved differential diagnosis and enhanced confidence in therapy monitoring.

About Siemens Medical Solutions

Siemens Medical Solutions is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Medical Solutions will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. The company delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Siemens Medical Sol
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
2. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
3. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
4. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
5. Siemens Extends Tender Offer for Acquisition of Dade Behring
6. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
7. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
8. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
9. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
10. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
11. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 USARAD Holdings Inc. a ... solutions provider, including SecondOpinions.com® – consumer division is ... advanced services. The telemedicine industry pioneer is now ... , Founded and established in 1963 as the ... began as a maternity care hospital with very ...
(Date:9/2/2014)... to announce that the following papers will be ... Congress 2014, taking place in Barcelona, Spain, 30 ... strut biodegradable polymer sirolimus-eluting stent versus durable polymer ... randomised, single-blind, non-inferiority trial, Windecker et al ... surface polymer, and drug release have improved clinical ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The global ... USD 8,918.8 million by 2020, growing at an estimated ... a new study by Grand View Research, Inc. Peripheral ... plague modification devices are used for treating peripheral arterial ... of atherosclerotic plaques in arteries. These devices are used ...
(Date:9/2/2014)... Denver, Colo. (PRWEB) September 02, 2014 ... reimagined patient care, has been selected from a group ... round of the 2014 PrIME Digital Health Challenge. The ... against one another, Tuesday, Sept. 9th at the CSU ... in 2012, MyRounding is based in Denver, Colo. The ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They can ... friends, sleeping and just coping well with daily activities. ... worldwide. The medications prescribed for these conditions frequently don’t ... cases of headache and back pain are of a mechanical ... detect and fix the cause. , When a sports ...
Breaking Medicine News(10 mins):Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... you,re ready to drive again , , WEDNESDAY, Dec. 10 (HealthDay ... wheel again after orthopedic surgery or injury, but knowing when it,s ... , Orthopedic surgeons weigh in on the issue in the December ... , "Deciding when a patient can return to driving is ...
... (OTC Pink Sheets: SNDY ) is pleased to announce that ... by over 10% compared to the same time period for 2007. ... $28,509 for the same month last year. This marks the second ... of October. , , The Mammo ...
... Inc., a leading,provider of software and databases for systems ... Singapore Immunology Network (SIgN) has become a,certified GeneGo Center ... MetaCore, training and advanced support. SIgN COE will ... "We are excited ...
... Facilities , , NEW ... process, a proven commitment to clinical quality earned SigmaCare(R) ... Metropolitan Jewish Health System,s (Metropolitan) skilled nursing facilities. ... nationally recognized nonprofit organization, operates Metropolitan Jewish Geriatric Center, ...
... Pharma Services, Goodwill, , , ... NYSE: MDZ ), a leading provider of products and ... fiscal 2008 performance. , Based on preliminary information, MDS ... of $1,210 million to $1,220 million and adjusted EBITDA in the ...
... Care Insurance While They,re Still Healthy Enough to Qualify , ... If you,ve put off getting long term care insurance, ... new administration,s health plan? "I wouldn,t advise it," says Denise ... (LTCFP), one of the nation,s most experienced long term care ...
Cached Medicine News:Health News:Returning to the Road Tricky After Injury 2Health News:Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year 2Health News:A*STAR's Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Obama Health Plan Not Likely to Embrace Long Term Care, Industry Leader Says 2
(Date:9/2/2014)... ResMed (NYSE: RMD ) has introduced ... the United States . The Astral platform ... life support ventilators. ResMed,s new Astral ... use for patients suffering from neuromuscular disease, chronic obstructive ... disorders. The U.S. launch comes on the heels of ...
(Date:9/2/2014)... 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... Administration (FDA) has granted orphan drug status to APD811 ... "The FDA Office of Orphan Products Development (OOPD) ... identify and designate drug candidates that could potentially treat ... of such products," said Craig M. Audet , ...
(Date:9/2/2014)... 2014   Intrexon Corporation (NYSE: ... that it has entered into an Exclusive Channel Collaboration ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... family of its marketed Active Pharmaceutical Ingredients (APIs) through ... . This collaboration will leverage Intrexon,s proprietary technology suite ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 2Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 3
Inquire...
Inquire...
... The compact Allegra X-22 Series is up to ... With a library of 11 rotors, the Allegra X-22 ... Features: Only 18 inches / 46 ... to 22,065 x g 3 different ways to ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products: